The genetics of human hypertension

Seminars in Nephrology

Volumn 22, Issue 1, 2002, Pages 27-34

  Crook, Errol D ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; GENE DELETION; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SYNDROME X;

DIABETES COMPLICATIONS; GENOTYPE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); METABOLIC SYNDROME X; MUTATION; OBESITY; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0036144630     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Genetic epidemiology of essential hypertension
2. Mutations contributing to human blood pressure variation
3. Commingling and segregation analysis of blood pressure in a French-Canadian population
4. Familial aggregation and genetic epidemiology of blood pressure
5. Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan
6. Genetic dissection of complex traits
7. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population
8. Systemic hypertension and the kidney in black patients
9. Does racial variation in risk factors explain black-white differences in the incidence of hypertension end-stage renal disease?
10. Differences in blacks and whites with essential hypertension: Biochemistry and endocrine
11. What is the role of obesity in hypertension and target organ injury in African Americans?
12. Genetics factors in human hypertension
13. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
14. A familial disorder simulating primary aldosteronism but with negligible aldosterone excretion
15. Hypertension increased aldosterone secretion and low plasma renin activity relieved by dexamethosone
16. Activating mineralocorticoid receptor mutation by hypertension exacerbated by pregnancy
17. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
18. Liddle's syndrome: Heritable human hypertension caused by mutations in beta subunit of the epithelial sodium channel
19. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism
20. A chimeric 11-beta hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
21. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase
22. Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess
23. Glucocorticoid-remediable aldosteronism and pregnancy
24. Molecular genetics of human hypertension
25. Orthostatic intolerance in tachycardia associated with norepinephrine transporter deficiency
26. Mitochrondial DNA mutations in patients with orthostatic hypotension
27. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus, and hypertension
28. Perixosome proliferator activated protein γ gene locus, body mass index and lipid values in normal subjects
29. Molecular basis of human hypertension: Role of angiotensinogen
30. Angiotensinogen is a risk factor for essential hypertension in Japan
31. Evaluation of the angiotensinogen locus in human essential hypertension: A European study
32. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans
33. Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies
34. A molecular variant of angiotensinogen associated with preeclampsia
35. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
36. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy
37. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy
38. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease
39. ACE gene polymorphism in childhood IgA nephropathy: Association with clinicopathologic findings
40. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension
41. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people
42. Insulin resistance, hyperinsulinemia, and hypertension: Causes, consequences, or merely correlations?
43. Insulin and hypertension in the NHLBI Family Heart Study: A sibpair approach to a controversial issue
44. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension
45. Association analyses of Nsi I RFLP of human insulin receptor gene in hypertensives
46. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome
47. Absence of genetic linkage between polymorphisms of the insulin receptor gene and essential hypertension
48. Incident type 2 diabetes mellitus in African American and white adults: The Atherosclerosis Risk in Communities Study
49. Endstage renal disease due to diabetic nephropathy in Mississippi: An examination of factors influencing renal survival in a population prone to late referral
50. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus
51. Diabetic nephropathy in African Americans
52. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure
53. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
54. Increased renal production of transforming growth factor-beta 1 in patients with type II diabetes
55. Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients
56. Polymorphisms of the transforming growth factor-β-1 gene in relation to myocardial infarction and blood pressure - The Etude Cas-Temon de l'Infarctus du Myocarde (ECTIM) Study
57. Lack of association between human TGF-β1 gene variants and primary hypertension